Browse drug classes

Find a class, then browse its recorded medications and Ontario listing requirements.

UNCLASSIFIED THERAPEUTIC AGENTS

Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.

FEBUXOSTAT: products 1 to 6 of 6.

Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.

Product / strength / formOntario listingRecorded ministry priceNext step
Auro-Febuxostat
80mg TabDIN 02533243
Off-Formulary Interchangeable, not an ODB benefit$1.3515per source unitRequirements & sourcesBuild cost plan
Febuxostat
80mg TabDIN 02539837
Off-Formulary Interchangeable, not an ODB benefit$1.3515per source unitRequirements & sourcesBuild cost plan
Jamp-Febuxostat
80mg TabDIN 02490870
Off-Formulary Interchangeable, not an ODB benefit$1.3515per source unitRequirements & sourcesBuild cost plan
Mar-Febuxostat
80mg TabDIN 02473607
Off-Formulary Interchangeable, not an ODB benefit$1.3515per source unitRequirements & sourcesBuild cost plan
Teva-Febuxostat
80mg TabDIN 02466198
Off-Formulary Interchangeable, not an ODB benefit$1.3515per source unitRequirements & sourcesBuild cost plan
Uloric
80mg TabDIN 02357380
Off-Formulary Interchangeable, not an ODB benefitNo price in this recordRequirements & sourcesBuild cost plan

Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.

Class sources and program rules

Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.

92:00 UNCLASSIFIED THERAPEUTIC AGENTS.

92:20 Biologic Response Modifiers.

92:36 Disease-Modifying Antirheumatic Agents.

92:44 Immunosuppressive Agents.

92:92 Other Miscellaneous Therapeutic Agents.